Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Leukaemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002865
What this trial is testing

High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia

Who this might be right for
Leukemia
Wake Forest University Health Sciences 25
Large-scale testing (Phase 3)Looking for participantsNCT04708054
What this trial is testing

Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome
M.D. Anderson Cancer Center 324
Testing effectiveness (Phase 2)UnknownNCT03188172
What this trial is testing

MUK Nine b: OPTIMUM Treatment Protocol

Who this might be right for
Multiple Myeloma
University of Leeds 95
Testing effectiveness (Phase 2)Ended earlyNCT00740181
What this trial is testing

Decitabine, Cytarabine, GCSF for Refractory AML/MDS

Who this might be right for
MyelodysplasiaLeukemia
Brown University 9
Testing effectiveness (Phase 2)Study completedNCT00002510
What this trial is testing

Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Temple University
Testing effectiveness (Phase 2)Active Not RecruitingNCT04128748
What this trial is testing

Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaBlasts More Than 10 Percent of Bone Marrow Nucleated CellsHigh Risk Myelodysplastic Syndrome+4 more
M.D. Anderson Cancer Center 52
Large-scale testing (Phase 3)UnknownNCT03384225
What this trial is testing

CBA Versus FBA Conditioning Followed by Haploidentical Allogeneic HSCT in Treatment of High Risk and Refractory AML

Who this might be right for
High Risk Acute Myeloid LeukemiaAllogeneic Hematopoeitic Stem Cell Transplantation
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 120
Early research (Phase 1)Ended earlyNCT02749708
What this trial is testing

Study of IRX5183 in Relapsed and Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)Chronic Myelomonocytic Leukemia (CMML)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 13
Testing effectiveness (Phase 2)Study completedNCT00005040
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Not applicableEnded earlyNCT01649791
What this trial is testing

Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Leukemia

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaChronic Lymphocytic LeukemiaStage 0 Chronic Lymphocytic Leukemia+2 more
Roswell Park Cancer Institute 8
Testing effectiveness (Phase 2)Ended earlyNCT01118013
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder+3 more
Alliance for Clinical Trials in Oncology 6
Testing effectiveness (Phase 2)Study completedNCT02197676
What this trial is testing

A Phase II Trial of SGI-110 in Patients With IPSS High and Int 2 Myelodysplastic Syndrome, Acute Myeloid Leukemia With 20-30% Marrow Blasts or Chronic Myelomonocytic Leukemia Type 2 Not Responding to Azacitidine or Decitabine After at Least 6 Courses or Relapsing After a Response

Who this might be right for
MDS
Groupe Francophone des Myelodysplasies 56
Testing effectiveness (Phase 2)Study completedNCT00004908
What this trial is testing

Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Northwestern University
Testing effectiveness (Phase 2)Ended earlyNCT05918055
What this trial is testing

Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Study completedNCT00452374
What this trial is testing

Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 48
Early research (Phase 1)Study completedNCT00077558
What this trial is testing

3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableUnknownNCT04406285
What this trial is testing

Effects of Periodized and Autoregulated Resistance Training in Haematological Cancer Patients During the Treatent.

Who this might be right for
FatigueLeukemiaLymphoma+1 more
Federal University of Health Science of Porto Alegre 66
Testing effectiveness (Phase 2)Ended earlyNCT01442714
What this trial is testing

Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & High-Risk MDS

Who this might be right for
LeukemiaAcute Myeloid Leukemia (AML)Myelodysplastic Syndromes (MDS)
Stanford University 33
Testing effectiveness (Phase 2)Study completedNCT02286726
What this trial is testing

CPX-351 in Treating Patients With Newly Diagnosed, High-Risk Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeSecondary Acute Myeloid Leukemia
M.D. Anderson Cancer Center 56
Early research (Phase 1)Looking for participantsNCT07177079
What this trial is testing

High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Kittika Poonsombudlert 30
Next Page